| HGNC Family | G protein-coupled receptors |
| Name | olfactory receptor, family 1, subfamily D, member 5 |
| Description | Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nThe neuropeptide Y (NPY) Y5 receptor plays a pivotal role in energy homeostasis and feeding regulation. Data from genetic ablation studies and selective pharmacological experiments indicate that the Y5 receptor—often acting in concert with the Y1 receptor—is critical for stimulating food intake and body weight gain. In diet‐induced obesity models, selective Y5 antagonism not only suppressed food consumption but also enhanced thermogenic mechanisms in adipose tissues, with compensatory hypothalamic changes in key appetite‐regulating neuropeptides further underscoring its role. These findings point to Y5 receptor signaling as a key contributor to both acute feeding behavior and chronic metabolic adaptations."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "8"}]}, {"type": "t", "text": "\n\nDisrupting or modulating Y5 receptor signaling also has profound effects on neuronal excitability and seizure dynamics. Electrophysiological investigations reveal that activation of the Y5 receptor contributes to the inhibition of excitatory synaptic transmission at key hippocampal synapses, thereby cooperating with other NPY receptor subtypes to attenuate epileptiform activity. Comprehensive mapping studies further demonstrate broad expression of Y5 in limbic and cortical regions—findings that correlate with its emerging role in the regulation of anxiety, mood, and cognitive processing. Although experimental overexpression of Y5 does not markedly alter mood-related outcomes, genetic deletion or adaptive changes following seizure-inducing insults underscore a more complex regulatory influence on neuronal plasticity and neuroprotection."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "9", "end_ref": "19"}]}, {"type": "t", "text": "\n\nRecent evidence further expands the functional repertoire of the Y5 receptor beyond neural circuits to include roles in non‐neuronal processes such as tumor progression. In hepatocellular carcinoma, for instance, up‐regulation of Y5 receptor expression—coupled with activation by NPY released from surrounding hepatocytes and modulated by factors like TGF‑β1 and dipeptidylpeptidase 4—has been linked to enhanced tumor growth and poorer survival. This oncogenic axis underscores the potential of Y5 receptor targeting as a therapeutic strategy in liver cancer."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "20"}]}, {"type": "t", "text": ""}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Paula D Raposinho, Thierry Pedrazzini, Richard B White, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Chronic neuropeptide Y infusion into the lateral ventricle induces sustained feeding and obesity in mice lacking either Npy1r or Npy5r expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocrinology (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/en.2003-0914"}], "href": "https://doi.org/10.1210/en.2003-0914"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14525913"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14525913"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Akane Ishihara, Akio Kanatani, Satoshi Mashiko, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A neuropeptide Y Y5 antagonist selectively ameliorates body weight gain and associated parameters in diet-induced obese mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0510320103"}], "href": "https://doi.org/10.1073/pnas.0510320103"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16636293"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16636293"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Satoshi Mashiko, Akane Ishihara, Hisashi Iwaasa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A pair-feeding study reveals that a Y5 antagonist causes weight loss in diet-induced obese mice by modulating food intake and energy expenditure."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Pharmacol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/mol.106.029991"}], "href": "https://doi.org/10.1124/mol.106.029991"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17105869"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17105869"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Satoshi Mashiko, Akane Ishihara, Hisashi Iwaasa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Effects of a novel Y5 antagonist in obese mice: combination with food restriction or sibutramine."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Obesity (Silver Spring) (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/oby.2008.223"}], "href": "https://doi.org/10.1038/oby.2008.223"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18421274"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18421274"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Hiroshi Higuchi, Takeshi Niki, Tomohiro Shiiya "}, {"type": "b", "children": [{"type": "t", "text": "Feeding behavior and gene expression of appetite-related neuropeptides in mice lacking for neuropeptide Y Y5 receptor subclass."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "World J Gastroenterol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3748/wjg.14.6312"}], "href": "https://doi.org/10.3748/wjg.14.6312"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19009645"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19009645"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Satoshi Mashiko, Ryuichi Moriya, Akane Ishihara, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Synergistic interaction between neuropeptide Y1 and Y5 receptor pathways in regulation of energy homeostasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Pharmacol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ejphar.2009.05.018"}], "href": "https://doi.org/10.1016/j.ejphar.2009.05.018"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19482021"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19482021"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Amy D Nguyen, Natalie F Mitchell, Shu Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Y1 and Y5 receptors are both required for the regulation of food intake and energy homeostasis in mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0040191"}], "href": "https://doi.org/10.1371/journal.pone.0040191"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22768253"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22768253"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Y-C Shi, C K Ip, F Reed, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Y5 receptor signalling counteracts the anorectic effects of PYY3-36 in diet-induced obese mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neuroendocrinol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jne.12483"}], "href": "https://doi.org/10.1111/jne.12483"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28485050"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28485050"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Hui Guo, Peter A Castro, Richard D Palmiter, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Y5 receptors mediate neuropeptide Y actions at excitatory synapses in area CA3 of the mouse hippocampus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurophysiol (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/jn.00532.2001"}], "href": "https://doi.org/10.1152/jn.00532.2001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11784771"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11784771"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Sergueï O Fetissov, Leah C Byrne, Hessameh Hassani, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Characterization of neuropeptide Y Y2 and Y5 receptor expression in the mouse hypothalamus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Comp Neurol (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cne.11047"}], "href": "https://doi.org/10.1002/cne.11047"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14755515"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14755515"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "David P D Woldbye, Avtandil Nanobashvili, Andreas T Sørensen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differential suppression of seizures via Y2 and Y5 neuropeptide Y receptors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurobiol Dis (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.nbd.2005.05.010"}], "href": "https://doi.org/10.1016/j.nbd.2005.05.010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15979311"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15979311"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Alessandra Oberto, Elena Acquadro, Thorsten Bus, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression patterns of promoters for NPY Y(1) and Y(5) receptors in Y(5)RitTA and Y(1)RVenus BAC-transgenic mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Neurosci (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1460-9568.2007.05631.x"}], "href": "https://doi.org/10.1111/j.1460-9568.2007.05631.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17614946"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17614946"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "M V Olesen, S H Christiansen, C R Gøtzsche, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Y5 neuropeptide Y receptor overexpression in mice neither affects anxiety- and depression-like behaviours nor seizures but confers moderate hyperactivity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuropeptides (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.npep.2012.01.002"}], "href": "https://doi.org/10.1016/j.npep.2012.01.002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22342800"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22342800"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Gunnar Sørensen, Morten Jensen, Pia Weikop, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neuropeptide Y Y5 receptor antagonism attenuates cocaine-induced effects in mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Psychopharmacology (Berl) (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00213-012-2651-y"}], "href": "https://doi.org/10.1007/s00213-012-2651-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22367168"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22367168"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Masanobu Ito, Yvan Dumont, Remi Quirion "}, {"type": "b", "children": [{"type": "t", "text": "Mood and memory-associated behaviors in neuropeptide Y5 knockout mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuropeptides (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.npep.2012.10.009"}], "href": "https://doi.org/10.1016/j.npep.2012.10.009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23218957"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23218957"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Angela Longo, Paolo Mele, Ilaria Bertocchi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Conditional inactivation of neuropeptide Y Y1 receptors unravels the role of Y1 and Y5 receptors coexpressing neurons in anxiety."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biol Psychiatry (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopsych.2014.01.009"}], "href": "https://doi.org/10.1016/j.biopsych.2014.01.009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24548641"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24548641"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Heidi Elbrønd-Bek, Janne Damm Olling, Casper R Gøtzsche, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neuropeptide Y-stimulated [(35) S]GTPγs functional binding is reduced in the hippocampus after kainate-induced seizures in mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Synapse (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/syn.21762"}], "href": "https://doi.org/10.1002/syn.21762"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24985894"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24985894"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Shin-Ichi Murase, Tomohiro Shiiya, Hiroshi Higuchi "}, {"type": "b", "children": [{"type": "t", "text": "Neuropeptide Y Y"}, {"type": "a", "children": [{"type": "t", "text": "sub"}], "href": "sub"}, {"type": "t", "text": "5"}, {"type": "a", "children": [{"type": "t", "text": "/sub"}], "href": "/sub"}, {"type": "t", "text": " receptor localization in mouse central nervous system."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain Res (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.brainres.2016.10.026"}], "href": "https://doi.org/10.1016/j.brainres.2016.10.026"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27984021"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27984021"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Helena Domin, Łukasz Przykaza, Danuta Jantas, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neuropeptide Y Y2 and Y5 receptors as promising targets for neuroprotection in primary neurons exposed to oxygen-glucose deprivation and in transient focal cerebral ischemia in rats."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuroscience (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neuroscience.2016.12.040"}], "href": "https://doi.org/10.1016/j.neuroscience.2016.12.040"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28057538"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28057538"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Peter Dietrich, Laura Wormser, Valerie Fritz, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Molecular crosstalk between Y5 receptor and neuropeptide Y drives liver cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI131919"}], "href": "https://doi.org/10.1172/JCI131919"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31999643"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31999643"}]}]}]}
|
| Synonyms | OR1D4, OR17-31, C17ORF2, OR17-2 |
| Proteins | OR1D5_HUMAN |
| NCBI Gene ID | 8386 |
| API | |
| Download Associations | |
| Predicted Functions |
 |
| Co-expressed Genes |
|
| Expression in Tissues and Cell Lines |
|
OR1D5 has 687 functional associations with biological entities spanning 8 categories (molecular profile, organism, functional term, phrase or reference, disease, phenotype or trait, chemical, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 44 datasets.
Click the + buttons to view associations for OR1D5 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of OR1D5 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of OR1D5 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of OR1D5 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of OR1D5 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of OR1D5 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of OR1D5 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of OR1D5 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of OR1D5 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with OR1D5 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with OR1D5 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by OR1D5 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with OR1D5 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at OR1D5 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of OR1D5 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of OR1D5 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing OR1D5 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of OR1D5 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of OR1D5 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of OR1D5 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving OR1D5 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving OR1D5 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving OR1D5 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing OR1D5 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by OR1D5 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by OR1D5 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by OR1D5 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of OR1D5 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of OR1D5 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with OR1D5 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for OR1D5 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of OR1D5 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of OR1D5 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEGG Pathways 2026 | pathways involving OR1D5 protein from the KEGG Pathways 2026 dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of OR1D5 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of OR1D5 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain OR1D5 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of OR1D5 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Reactome Pathways 2014 | pathways involving OR1D5 protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving OR1D5 protein from the Reactome Pathways 2024 dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of OR1D5 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of OR1D5 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with OR1D5 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2014 | pathways involving OR1D5 protein from the Wikipathways Pathways 2014 dataset. | |
| WikiPathways Pathways 2024 | pathways involving OR1D5 protein from the WikiPathways Pathways 2024 dataset. | |
